Heart Disease Trial, Recruiting NCT06182683 Sponsor: Korea University Guro Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06182683
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 19 years of age
  • People who are having a coronary stent procedure to treat stable angina or an acute coronary syndrome (a serious heart condition including heart attacks)
  • People who have given their informed consent to take part

Who may not be able to join:

  • People who have a history of bleeding problems or blood disorders
  • People who are experiencing severe, treatment-resistant shock caused by the heart not pumping properly
  • People who have previously had a blood clot form inside a stent
  • People whose life expectancy is estimated to be less than one year
  • People whose heart pumping function (measured as left ventricular ejection fraction) is at or above 20% — (confirm with trial site, as this wording may indicate a lower pumping function is required)
  • Women who are currently breastfeeding, pregnant, or planning to become pregnant
  • People whom the trial investigator considers unsuitable for participation for any reason
  • People who are unwilling to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dong Oh Kang, MD, PhD, Korea University Guro Hospital

Phone: 82-2-2626-3184

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Korea University Guro Hospital
Registry
ClinicalTrials.gov
Start date
30 November 2023
Est. completion
31 December 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Rate of target vessel failure (TVF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov